{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:52:08Z","timestamp":1791978728682,"version":"4.4.0"},"reference-count":3,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/qjmed\/hcag278","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:39:27Z","timestamp":1791027567000},"source":"Crossref","is-referenced-by-count":0,"title":["Healthy-adherer bias may confound the association between PCSK9 inhibitors and incident heart failure"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1594-9145","authenticated-orcid":false,"given":"Esteban","family":"Cardenas-Duran","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hospital General Reynosa \u201cDr. Jos\u00e9 Mar\u00eda Cant\u00fa Garza,\u201d Reynosa, Tamaulipas,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6570-007X","authenticated-orcid":false,"given":"Hefziba","family":"Lorences-Noguera","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital General Reynosa \u201cDr. Jos\u00e9 Mar\u00eda Cant\u00fa Garza,\u201d Reynosa, Tamaulipas,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"2026101407364365900_hcag278-B1","doi-asserted-by":"publisher","first-page":"hcag235","DOI":"10.1093\/qjmed\/hcag235","article-title":"Association between PCSK9 inhibitor use and risk of incident heart failure in patients with dyslipidemia","author":"Wu","year":"2026","journal-title":"QJM"},{"key":"2026101407364365900_hcag278-B2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamacardio.2017.3451","article-title":"Association of prior authorization and out-of-pocket costs with patient access to PCSK9 inhibitor therapy","volume":"2","author":"Navar","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026101407364365900_hcag278-B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcag278\/71610715\/hcag278.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcag278\/71610715\/hcag278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:36:46Z","timestamp":1791977806000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article\/doi\/10.1093\/qjmed\/hcag278\/8866654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":3,"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcag278","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"hcag278"}}